AYTU
Price:
$1.91
Market Cap:
$11.74M
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2008-09-25
Stock Exchange
NASDAQ
Ticker
AYTU
According to Aytu BioPharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.99. This represents a change of -1.40% compared to the average of 1.01 of the last 4 quarters.
The mean historical Current Ratio of Aytu BioPharma, Inc. over the last ten years is 1.96. The current 0.99 Current Ratio has changed 4.99% with respect to the historical average. Over the past ten years (40 quarters), AYTU's Current Ratio was at its highest in in the September 2015 quarter at 6.36. The Current Ratio was at its lowest in in the August 2014 quarter at 0.05.
Average
1.96
Median
1.03
Minimum
0.84
Maximum
5.47
Discovering the peaks and valleys of Aytu BioPharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 908.47%
Maximum Annual Current Ratio = 5.47
Minimum Annual Increase = -81.68%
Minimum Annual Current Ratio = 0.84
Year | Current Ratio | Change |
---|---|---|
2024 | 0.99 | -5.75% |
2023 | 1.06 | 13.48% |
2022 | 0.93 | -3.29% |
2021 | 0.96 | -63.69% |
2020 | 2.65 | -7.80% |
2019 | 2.87 | 2.97% |
2018 | 2.79 | 232.57% |
2017 | 0.84 | -16.25% |
2016 | 1.00 | -81.68% |
2015 | 5.47 | 908.47% |
The current Current Ratio of Aytu BioPharma, Inc. (AYTU) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.99
5-year avg
1.32
10-year avg
1.96
Aytu BioPharma, Inc.’s Current Ratio is less than Aquestive Therapeutics, Inc. (7.49), less than Evoke Pharma, Inc. (1.28), greater than Adamis Pharmaceuticals Corporation (0.58), less than Guardion Health Sciences, Inc. (16.67), less than AcelRx Pharmaceuticals, Inc. (4.04), less than Shionogi & Co., Ltd. (6.22), less than Sunshine Biopharma, Inc. (4.86), less than Alimera Sciences, Inc. (2.79), less than China SXT Pharmaceuticals, Inc. (1.60), less than Shuttle Pharmaceuticals Holdings, Inc. (1.79), less than Lifecore Biomedical, Inc. (1.83), less than Petros Pharmaceuticals, Inc. (1.40), less than Ironwood Pharmaceuticals, Inc. (3.92), greater than Neptune Wellness Solutions Inc. (0.23), less than Flora Growth Corp. (1.16), less than Jupiter Wellness, Inc. (1.92), less than Sonoma Pharmaceuticals, Inc. (3.12), less than Esperion Therapeutics, Inc. (1.97), less than Journey Medical Corporation (1.36), less than Avadel Pharmaceuticals plc (2.82),
Company | Current Ratio | Market cap |
---|---|---|
7.49 | $468.96M | |
1.28 | $4.69M | |
0.58 | $7.25M | |
16.67 | $4.35M | |
4.04 | $14.58M | |
6.22 | $12.15B | |
4.86 | $5.78M | |
2.79 | $301.29M | |
1.60 | $1.66M | |
1.79 | $4.71M | |
1.83 | $220.59M | |
1.40 | $3.37M | |
3.92 | $669.31M | |
0.23 | $906.41K | |
1.16 | $20.05M | |
1.92 | $49.33M | |
3.12 | $3.68M | |
1.97 | $392.45M | |
1.36 | $110.27M | |
2.82 | $1.43B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aytu BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aytu BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Aytu BioPharma, Inc.'s Current Ratio?
How is the Current Ratio calculated for Aytu BioPharma, Inc. (AYTU)?
What is the highest Current Ratio for Aytu BioPharma, Inc. (AYTU)?
What is the 3-year average Current Ratio for Aytu BioPharma, Inc. (AYTU)?
What is the 5-year average Current Ratio for Aytu BioPharma, Inc. (AYTU)?
How does the current Current Ratio for Aytu BioPharma, Inc. (AYTU) compare to its historical average?